Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tmnors in ODC/Ras transgenic mice

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5696-5703

  Lan, Li ^a   Trempus, Carol ^b   Gilmour, Susan K ^a  

^a LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA FRAGMENT; EFLORNITHINE; ORNITHINE DECARBOXYLASE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; ONCOGENE H RAS; ONCOGENE RAS; PRIORITY JOURNAL; SKIN CARCINOMA; TRANSGENIC MOUSE; TUMOR REGRESSION; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL DIVISION; CROSSES, GENETIC; EFLORNITHINE; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; GENES, RAS; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; ORNITHINE DECARBOXYLASE; RNA, MESSENGER; SKIN NEOPLASMS; TRANSGENES;

EID: 0034667393     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Recent advances in the biochemistry of polyamines in eukaryotes
2. Polyamines
3. Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy
4. The induction of ornithine decarboxylase as an early, possibly obligatory event in mouse skin carcinogenesis
5. Heterogeneity of ornithine decarboxylase expression in 12-O-tetradecanoylphorbol-13-acetate-treated mouse skin and in epidermal tumors
6. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis
7. Constitutively elevated levels of ornithine and polyamines in mouse epidermal papillomas
8. The ornithine decarboxylase gene is a transcriptional target of c-Myc
9. The role of ornithine decarboxylase in c-Myc-induced apoptosis
10. Involvement of Myc targets in c-myc and N-myc induced human tumors
11. Polyamines are essential for cell transformation by pp60(V-SRC) delineation of molecular events relevant for the transformed phenotype
12. Ornithine decarboxylase induction in transformation by H-Ras and RhoA
13. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells
14. Molecular analysis of chemical carcinogenesis in the skin
15. Ras oncogenes in human cancer: A review
16. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway
17. Human breast cancer: Correlation of relapse and survival with amplification of the Her-2/neu oncogene
18. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
19. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin
20. Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase
21. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: Effects of phorbol esters and retinoic acid
22. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice
23. Chemically induced skin carcinogenesis in a transgenic mouse line (TG.AC) carrying a v-Ha-ras gene
24. Follicular origin of epidermal papillomas in v-Ha-ras transgenic TG.AC mouse skin
25. Ornithine decarboxylase overexpression is a sufficient condition for tumor promotion in mouse skin
26. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and produce analogues
27. α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin
28. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine bio-synthesis by α-difluoromethylornithine
29. Treatment of recurrent gliomas with 1,3-bis(2-chloroethyl-1-nitrosourea and α-difluoromethylornithine
30. Development of α-difluoromethylornithine (DFMO) as a chemoprevention agent
31. Induction of the polyamine biosynthetic enzymes in mouse epidermis by tumor promoting agents
32. Ornithine decarboxylase expression leads to translocation and activation of protein kinase CK2 in vivo
33. Angiogenesis is an early event in the development of chemically induced skin tumors
34. Focal transgene expression associated with papilloma development in v-Ha-ras-transgenic TG.AC mice
35. Anatomical methods in cell death
36. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice
37. Polyamines regulate expression of the neoplastic phenotype in mouse skin
38. Induction of cyclin D1 overexpression by activated ras
39. Early overexpression of cyclin D1 protein in mouse skin carcinogenesis
40. The D-type cyclins and their role in tumorigenesis
41. Expression of cyclin D1 and c-Ki-ras gene product in human epithelial ovarian tumors
42. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogene ras pathway in vivo
43. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia
44. Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit
45. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1)
46. Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors
47. Alterations in murine keratinocyte differentiation induced by activated ras(Ha) genes are mediated by protein kinase C-α
48. Vascular endothelial growth factor is a secreted angiogenic mitogen
49. Vascular permeability factor, an endothelial cell mitogen related to PDGF
50. Vascular permeability factor, tumor angiogenesis and stroma generation
51. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
52. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
53. The mouse gene for vascular endothelial growth factor
54. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels
55. Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons
56. An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue
57. Polyamine biosynthesis and accumulation during the GI to S Phase transition
58. Cell cycle dependent expression of human ornithine decarboxylase
59. Effect of elevated levels of ornithine decarboxylase on cell cycle progression in skin
60. Analysis of ras gene mutational spectra in epidermal papillomas from K6/ODC transgenic mice
61. Pathology of human and experimental skin tumors
62. Increasing complexity of the Ras signaling pathway
63. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway
64. Angiostatin induces and sustains dormancy of human primary tumors in mice
65. Endostatin. An endogenous inhibitor of angiogenesis and tumor growth
66. Tumor angiogenesis
67. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis
68. Angiogenic growth factors
69. Tumor angiogenesis and polyamines: α-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits B16 melanoma-induced angiogenesis in ovo and the proliferation of vascular endothelial cells in vitro
70. Antimetastatic activity of DL-α-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice
71. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice
72. Role of ornithine decarboxylase in epidermal tumorigenesis
73. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma
74. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally distinguishable from a fragment of thrombospondin
75. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
76. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
77. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF)
78. Accelerated wound healing in mice with a disruption of the thrombospondin 2 gene
79. Tumor induction of VEGF promoter activity in stromal cells
80. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium